Jun 23, 2016 9:00 am EDT Capricor Therapeutics Provides Enrollment Update on HOPE Clinical Trial in Duchenne Muscular Dystrophy
Jun 16, 2016 8:30 am EDT Capricor Therapeutics Reports Positive 12-Month Data from the DYNAMIC Clinical Trial
May 12, 2016 4:05 pm EDT Capricor Therapeutics Provides Corporate Update and Reports First Quarter 2016 Financial Results
May 05, 2016 4:05 pm EDT Capricor Therapeutics to Hold First Quarter 2016 Business Update and Financial Results Conference Call on May 12, 2016 at 4:30 p.m. EDT
Apr 04, 2016 8:30 am EDT Capricor Therapeutics Announces DSMB Recommends Continuation of HOPE-Duchenne Clinical Trial
Mar 17, 2016 4:00 pm EDT Capricor Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Business Update
Mar 17, 2016 12:50 pm EDT Capricor Awarded $3.4 Million Grant from California Institute for Regenerative Medicine